SAfeguarding female FERtility -development of human-relevant in vitro tools for reproductive toxicity
SAFER aims to develop innovative, animal-free assays for assessing reproductive toxicity in women, using advanced technologies to identify harmful chemicals and promote safer environments.
Projectdetails
Introduction
Chemical health risk assessment has failed to safeguard fertility in women. Women and their oocytes are exposed to pervasive mixtures of human-made chemicals that correlate with reproductive ageing and infertility. Only 0.5% of the chemicals on the European market have been well characterized for health risks, and reproductive toxicity in women is typically not covered due to missing tools.
European Growth Strategy
The new European Growth Strategy aims at sustainable growth, zero-pollution, and safe chemicals. While the need for increased chemical testing is tangible, there is a movement to phase out animal experiments. This creates a huge challenge to deliver on the vision of a safe and toxic-free environment.
Project Overview
Here, I will develop new high-content assays for reproductive toxicity in women. SAFER is built on my exceptional ovary biobank, established stem cell lines, and multi-omics technologies.
Methodology
Using chemically exposed ovarian tissue and stem cell-derived blastoid cultures, SAFER will map mechanisms mediating toxicity by high-resolution epigenetic and transcriptomic analyses. Model chemicals are chosen based on:
- Ubiquitous presence in women
- Significant associations to decreased ovarian function, as shown by my cohort studies.
The identified mechanisms will be tailored into reporter genes that I will insert into new immortalized human ovarian cells as well as stem cells, and develop into high-content screening assays. The product of SAFER is novel in vitro tools for screening of female reproductive toxicants.
Impact
Taken together, SAFER sets an example for animal-free derivation of assays for chemical safety assessment. SAFER tools will contribute to the identification and restriction of chemicals that pose a hazard to women’s health. This is an important step in the global movement towards a non-toxic, safe environment.
Conclusion
Starting a family is a basic human right, and whether to have a child or not should be decided by the prospective parents, not by the chemicals in their environment.
Financiële details & Tijdlijn
Financiële details
Subsidiebedrag | € 2.000.000 |
Totale projectbegroting | € 2.000.000 |
Tijdlijn
Startdatum | 1-10-2024 |
Einddatum | 30-9-2029 |
Subsidiejaar | 2024 |
Partners & Locaties
Projectpartners
- KAROLINSKA INSTITUTETpenvoerder
Land(en)
Vergelijkbare projecten binnen European Research Council
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Developing a human-based stem cell model for reproductive toxicityDeveloping a high-throughput human-based assay for male reproductive toxicity to enhance drug safety testing and reduce reliance on animal models. | ERC Proof of... | € 150.000 | 2024 | Details |
Human blastoids: a drug discovery platform for women’s reproductive healthBLASTOID-DISCOVERY aims to utilize human blastoids as a scalable and ethical model for drug discovery to enhance women's reproductive health and reduce development costs. | ERC Proof of... | € 150.000 | 2023 | Details |
Representative, Reliable and Reproducible in vitro Models of the Human TestesThe project aims to develop a reliable preclinical model of human testes using tailored hydrogels to improve male infertility treatments through high-throughput experimentation and automated analysis. | ERC Starting... | € 1.499.980 | 2022 | Details |
dAta-dRiven integrated approaches to CHemIcal safety assessMEnt and Drug dEvelopmentThe ARCHIMEDES project aims to revolutionize chemical and drug development by integrating toxicogenomics, AI, and a Knowledge Graph to enhance safety and innovation in a regulatory-compliant manner. | ERC Consolid... | € 2.000.000 | 2022 | Details |
Molecular mechanisms through which oocytes evade ageingThis project aims to uncover the molecular mechanisms that allow dormant oocytes to maintain cellular fitness and how these mechanisms fail with age, enhancing understanding of female fertility and ageing. | ERC Consolid... | € 1.999.796 | 2024 | Details |
Developing a human-based stem cell model for reproductive toxicity
Developing a high-throughput human-based assay for male reproductive toxicity to enhance drug safety testing and reduce reliance on animal models.
Human blastoids: a drug discovery platform for women’s reproductive health
BLASTOID-DISCOVERY aims to utilize human blastoids as a scalable and ethical model for drug discovery to enhance women's reproductive health and reduce development costs.
Representative, Reliable and Reproducible in vitro Models of the Human Testes
The project aims to develop a reliable preclinical model of human testes using tailored hydrogels to improve male infertility treatments through high-throughput experimentation and automated analysis.
dAta-dRiven integrated approaches to CHemIcal safety assessMEnt and Drug dEvelopment
The ARCHIMEDES project aims to revolutionize chemical and drug development by integrating toxicogenomics, AI, and a Knowledge Graph to enhance safety and innovation in a regulatory-compliant manner.
Molecular mechanisms through which oocytes evade ageing
This project aims to uncover the molecular mechanisms that allow dormant oocytes to maintain cellular fitness and how these mechanisms fail with age, enhancing understanding of female fertility and ageing.
Vergelijkbare projecten uit andere regelingen
Project | Regeling | Bedrag | Jaar | Actie |
---|---|---|---|---|
Cultivating hope one star sperm at a timeSpermotile aims to revolutionize male infertility treatment by providing an automated, AI-driven sperm selection platform that enhances ART success rates and reduces costs for clinics and patients. | EIC Transition | € 2.499.906 | 2025 | Details |
Fusion of Ecological protection and stimulation of cropsI am BioTech onderzoekt biologische oplossingen om de negatieve impact van traditionele meststoffen en bestrijdingsmiddelen op het ecosysteem te verminderen. | Mkb-innovati... | € 20.000 | 2021 | Details |
LIFE Chemical Ambassadors for EuropeLIFE ChemBee aims to empower consumers to change purchasing behaviors through the Household Check tool, increasing awareness of harmful substances and reducing emissions in 43,000 households across Europe. | LIFE Standar... | € 1.199.786 | 2022 | Details |
Multi-organ toxicity and efficacy test platform for Personalized medicine & Drug developmentCherry Biotech aims to revolutionize drug development and personalized medicine by providing a patented 3D cell culture platform that enhances predictability and reduces reliance on animal testing. | EIC Accelerator | € 2.499.831 | 2024 | Details |
Awareness raising and behaviour change program to empower consumer-citizens to live toxic-free lives, reduce chemical risks on their health and the environment, and to upscale their positive impactThe project aims to raise awareness and drive behavior change regarding harmful chemicals in consumer goods in the CEE region, mobilizing citizens and influencing policy for safer alternatives. | LIFE Standar... | € 1.199.134 | 2023 | Details |
Cultivating hope one star sperm at a time
Spermotile aims to revolutionize male infertility treatment by providing an automated, AI-driven sperm selection platform that enhances ART success rates and reduces costs for clinics and patients.
Fusion of Ecological protection and stimulation of crops
I am BioTech onderzoekt biologische oplossingen om de negatieve impact van traditionele meststoffen en bestrijdingsmiddelen op het ecosysteem te verminderen.
LIFE Chemical Ambassadors for Europe
LIFE ChemBee aims to empower consumers to change purchasing behaviors through the Household Check tool, increasing awareness of harmful substances and reducing emissions in 43,000 households across Europe.
Multi-organ toxicity and efficacy test platform for Personalized medicine & Drug development
Cherry Biotech aims to revolutionize drug development and personalized medicine by providing a patented 3D cell culture platform that enhances predictability and reduces reliance on animal testing.
Awareness raising and behaviour change program to empower consumer-citizens to live toxic-free lives, reduce chemical risks on their health and the environment, and to upscale their positive impact
The project aims to raise awareness and drive behavior change regarding harmful chemicals in consumer goods in the CEE region, mobilizing citizens and influencing policy for safer alternatives.